|
 |
TygacilThis page contains recent news articles, when available, and an overview of Tygacil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....(Nasdaq: VPHM) Vancocin, Theravance's (Nasdaq: THRX) Vibativ, Cubist Pharmaceutical's (Nasdaq: CBST) Cubicin, Pfizer's (NYSE: PFE) Zyvox and Tygacil. Benzinga Business in the courts - Dec 20, 2009 ...sued Sandoz Inc. for allegedly infringing a US patent with plans to market a generic version of the antibacterial medication Tygacil. ... The News Journal Court Report - Dec 20, 2009 ...to manufacture a generic version of Wyeth's Tygacil® (tigecycline injectible, used for the treatment of complicated skin and skin structure infections, ... Patent Docs (blog) Zacks Analyst Blog Highlights: Johnson & Johnson, ViroPharma, Theravance ... - Jan 4, 2010 ...(Nasdaq: THRX) Vibativ, Cubist Pharmaceutical's (Nasdaq: CBST) Cubicin, Pfizer's (NYSE: PFE) Zyvox and Tygacil. Want more from Zacks Equity Research? ... FOXBusiness Analyst - Zacks Analyst Blog Highlights: Theravance, ViroPharma, Pfizer ... - Oct 27, 2009 Vibativ will have to jostle for space against products like ViroPharma's (Nasdaq: VPHM) Vancocin, Pfizer's (NYSE: PFE) Zyvox and Tygacil. ... Ad-Hoc-News (Pressemitteilung) FDA Approves Superbug Antibiotic, Tygacil (tigecycline) - Jun 17, 2005 The US FDA has approved Tygacilâ„¢ (tigecycline), a novel IV antibiotic with a broad spectrum of antimicrobial activity, including activity against the ... Medical News Today - Medical News Today (press release) Wyeth seeks OK to market Tygacil for pneumonia - Oct 24, 2007 NEW YORK, Oct 24 (Reuters) - Wyeth (WYE.N) on Wednesday said it has asked US regulators to approve use of its already marketed Tygacil antibiotic as a ... Reuters Wyeth launches antibiotic Tygacil for Indian market - Jun 22, 2007 NEW DELHI, June 22 (Reuters) - Wyeth Ltd. (WLED.BO), the Indian arm of US-based drug maker Wyeth WYE.N, on Friday launched 'Tygacil', an intravenous ... Reuters Tygacil Receives 'Positive Opinion' From CHMP, Europe - Mar 3, 2006 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it has received a "positive opinion" recommending approval for the introduction ... Medical News Today - Medical News Today (press release) Wyeth withdraws European application to add use for Tygacil - Apr 24, 2008 Wyeth Pharmaceuticals said Thursday it is withdrawing its application for an extension to the European marketing authorization for Tygacil. ... Bizjournals.com US delays OK to broaden use of Wyeth antibiotic - May 29, 2008 N antibiotic Tygacil for treating pneumonia outside hospitals or nursing homes as they ... Tygacil, which had about $138 million in sales last year and is ... Reuters India Wyeth Drug Gets Priority Review - Jan 28, 2005 Wyeth (WYE :NYSE) Friday said the Food and Drug Administration granted priority review status to its experimental antibiotic Tygacil. ... TheStreet.com - TheStreet.com (subscription) Wyeth pulls pneumonia drug application in Europe - Apr 23, 2008 MADISON, NJ --Drug developer Wyeth said Wednesday it is withdrawing its European application for approval of Tygacil as a pneumonia treatment. ... Boston Globe Drug approved to battle superbug - Jul 11, 2006 Trials of the drug Tygacil have shown its ability to combat certain infection strains that have become resistant to medicines, including MRSA and the E.coli ... BBC News FDA Approves Superbug Antibiotic, Tygacil (tigecycline) - Jun 20, 2005 The US FDA has approved Tygacilâ„¢ (tigecycline), a novel IV antibiotic with a broad spectrum of antimicrobial activity, including activity against the ... i-newswire.com Wyeth Sees Effexor Growth Slowing - Apr 20, 2005 The agency has designated Tygacil a fast-track review candidate. In other financial matters, CFO Martin describes as "adequate" the reserve set aside for ... TheStreet.com - TheStreet.com (subscription) New Data Examines TYGACIL (Tigecycline) in Patients with Community- … - Sep 29, 2006 MADISON, NJ, Sept. 29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , presented data today from Phase III studies in patients with ... Free with registration - PR Newswire - AccessMyLibrary.com … Receives Approvable Letter From FDA For TYGACIL For The Treatment ... - May 30, 2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the US Food and Drug Administration (FDA) has issued an approvable letter for the ... Medical News Today - Medical News Today (press release) … Wyeth's Supplemental New Drug Application for Tygacil for the... - Oct 24, 2007 FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research FDA Grants Antibiotic Tygacil(TM) NDA Priority Review Status - Jan 31, 2005 Tygacil is the first in a new class of antibiotics called glycylcyclines to be submitted for regulatory approval - It was designed to circumvent two major ... i-newswire.com Press Release: New Data Examines TYGACIL (Tigecycline) in Patients … - Sep 29, 2006 New Data Examines TYGACIL (Tigecycline) in Patients with Community-Acquired Pneumonia. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research New Data Highlight TYGACIL (tigecycline) In Vitro Activity Against … - Dec 16, 2005 WASHINGTON, Dec. 16 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , presented data today from multiple studies that indicate the in ... Free with registration - PR Newswire - AccessMyLibrary.com … Receives Approvable Letter from FDA for TYGACIL for the Treatment... - May 29, 2008 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research New Broad-spectrum Antibiotic Tygacil* (tigecycline) Receives... - May 4, 2006 Tygacil* (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe. Tygacil is produced by Wyeth and is indicated for ... Medical News Today - Medical News Today (press release) Wyeth introduces Tygacil in India - Jun 30, 2007 Wyeth has introduced Tygacil (tigecycline) in select cities in India following its approval by the Drug Controller General of India. Tygacil is the first ... Express Pharma New Broad-Spectrum Antibiotic Tygacil (Tigecycline) Receives Approval... - May 2, 2006 MAIDENHEAD, UNITED KINGDOM -- May 2, 2006 – Tygacil® (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe. ... DG News Article: TYGACIL approved for treatment of patients with CAP.(RECENT ... - Jul 1, 2008 TYGACIL approved for treatment of patients with CAP.(RECENT APPROVALS) ... find Pharmaceutical Processing articles. The FDA has issued an approvable letter ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research FDA Approvals: Tygacil, Keppra, Enbrel - Jun 30, 2005 June 30, 2005 — The US Food and Drug Administration (FDA) has approved tigecycline for the treatment of complicated intra-abdominal infections and ... Medscape FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil - Oct 25, 2007 The FDA has received Wyeth Pharmaceuticals' supplemental new drug application for the antibiotic Tygacil for the treatment of patients with ... FDA news - FDA news (subscription) Press Release: FDA APPROVES TYGACIL(TM), FIRST-IN-CLASS … - Jun 16, 2005 FDA APPROVES TYGACIL(TM), FIRST-IN-CLASS ANTIBIOTIC. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research ICAAC: Tygacil Beats Resistant Acinetobacter - Sep 29, 2006 By Michael Smith, Senior Staff Writer, MedPage Today. SAN FRANCISCO, Sept. 28 -- The antibiotic Tygacil (tigecycline) is highly effective against multidrug ... MedPage Today … Required to Support European Approval of CAP Indication for TYGACIL... - Apr 23, 2008 This extension sought approval of TYGACIL for the treatment of ... TYGACIL is currently approved in Europe for the treatment of complicated intra-abdominal ... Pay-Per-View - PR Newswire - HighBeam Research Wyeth's antibiotic Tygacil launched in UK. - Jul 24, 2006 Wyeth's antibiotic Tygacil launched in UK. US drug major Wyeth has launched its broad spectrum antibiotic Tygacil (tigecycline) in the UK. ... $9.94 - Pharma Marketletter - Alacra Store Wyeth's Tygacil antibiotic will be manufactured in Carolina plant - Jun 23, 2005 BY MARIALBA MARTINEZ of Caribbean Business. The recent Food & Drug Administration approval of Wyeth's Tygacil could add $1 billion in annual sales to the ... Puerto Rico Herald Wyeth to submit Tygacil sNDA for CAP. - Jul 23, 2007 Wyeth to submit Tygacil sNDA for CAP. USA-based drugmaker Wyeth Pharmaceuticals, a division of Wyeth, has announced plans to submit a supplemental New Drug ... $9.94 - Pharma Marketletter - Alacra Store … Required to Support European Approval of CAP Indication for TYGACIL... - Apr 23, 2008 This extension sought approval of TYGACIL for the treatment of ... TYGACIL is currently approved in Europe for the treatment of complicated intra-abdominal ... Pay-Per-View - PR Newswire Europe - HighBeam Research ALSO NOTED: Wyeth releases Tygacil data; Eurand inks deal with GSK; … - Oct 3, 2006 ...> Wyeth has released data from a Phase III trial of Tygacil that shows a statistically similar ability to treat community acquired pneumonia as an existing ... FierceBiotech FDA approves Tygacil, first-in-class antibiotic. - Jun 16, 2005 Tygacil is indicated for the treatment of complicated intra-abdominal ... Tygacil can be used as an empiric monotherapy to treat a variety of cIAI and cSSSI ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Wyeth Pulls EU Application for Expanded Tygacil Indication - Apr 30, 2008 Wyeth has withdrawn its application to extend its European marketing authorization for Tygacil to treat community-acquired pneumonia (CAP). ... FDA news - FDA news (subscription) Wyeth submits Tygacil sNDA for CAP. - Oct 29, 2007 US drug major Wyeth says that the Food and Drug Administration has accepted a supplemental New Drug Application seeking clearance for the use of its ... $4.95 - Pharma Marketletter - ECNext Wyeth's Tygacil gets nod from EMEA's CHMP.(Wyeth Pharmaceuticals, … - Mar 13, 2006 US drug major Wyeth Pharmaceuticals has received a positive opinion from the European Medicine Agency's Committee for Medicinal Products for Human Use ... Free with registration - Pharma Marketletter - AccessMyLibrary.com … : New data suggests that the antibiotic Tygacil (tigecycline) is... - Dec 19, 2005 Nearly 99% of Acinetobacter isolates tested were susceptible to Tygacil. ... Tygacil, a glycylcycline, is an intravenous (IV) antibiotic with an expanded ... OnMedica … Release: New Broad-Spectrum Antibiotic Tygacil[x] (tigecycline)... - May 2, 2006 New Broad-Spectrum Antibiotic Tygacil[x] (tigecycline) Receives Approval for Use in Europe Today. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: FDA Grants Tygacil(TM) (Tigecycline) NDA Priority … - Jan 28, 2005 FDA Grants Tygacil(TM) (Tigecycline) NDA Priority Review Status; Wyeth Seeking Expedited Approval For Treatment of Complicated Intra-abdominal Infections ... Pay-Per-View - PR Newswire - HighBeam Research International Approvals: Tygacil, DepoDur, and Zyvox - May 8, 2006 May 8, 2006 — The European Commission has approved tigecycline injection for the treatment of complicated intra-abdominal infections and complicated skin ... Medscape Bacterial Resistance; FDA grants Tygacil NDA priority review status - Feb 28, 2005 2005 FEB 28 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that the US Food and Drug Administration (FDA) ... Pay-Per-View - Anti-Infectives Week - Factiva, from Dow Jones Wyeth's Tygacil Recommended for EU Approval - Mar 6, 2006 A European Union (EU) pharmaceutical advisory committee has recommended approval of Wyeth Pharmaceuticals' first-in-class antibiotic Tygacil (tigecycline), ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones Bacterial Resistance; FDA grants Tygacil NDA priority review status - Mar 4, 2005 2005 MAR 4 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that the US Food and Drug Administration (FDA) granted ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Tigecycline (Tygacil): the first in the glycylcycline class of... - Apr 1, 2006 Tigecycline is the first drug in the glycylcycline class of antibiotics. Although it is structurally related to minocycline, alterations to the molecule ... Free with registration - Baylor University Medical Center... - AccessMyLibrary.com Bacterial Resistance; FDA grants Tygacil NDA priority review status - Mar 5, 2005 2005 MAR 5 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that the US Food and Drug Administration (FDA) granted ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … injectable is first in new class of antibiotics.(Tygacil for drug... - Jul 11, 2005 For more than a decade now, pharmacists have seen an escalating incidence of resistance to currently used antibiotics. At an alarming rate, antibiotics have ... Free with registration - Drug Topics - AccessMyLibrary.com Tygacil[TM] (tigecycline).(New Drug)(Brief Article) - Aug 1, 2005 Tygacil, a broad-spectrum intravenous antibiotic that is the first in a new ... In clinical trials, empiric monotherapy with Tygacil demonstrated cSSSI and ... $4.95 - Clinician Reviews - ECNext Q4 2004 WYETH Earnings Conference Call - Part 1. - Jan 31, 2005 I'm very pleased to note that FDA granted Tygacil priority review status last ... We now expect to launch the launch of Tygacil in the middle of this year ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth's Tygacil cleared in European Union.(approval of glycylcycline)(... - May 15, 2006 US drug major Wyeth says that its broad-spectrum antibiotic Tygacil (tigecycline) has become the first-in-class glycylcycline to be approved in Europe for ... $4.95 - Pharma Marketletter - ECNext New data highlight Tygacil (tigecycline) in vitro activity against... - Dec 16, 2005 Nearly 99% of Acinetobacter isolates tested were susceptible to Tygacil. ... Tygacil, a first-in-class glycylcycline, is an IV antibiotic with an expanded ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Article: FDA Approves New Antibiotic Tygacil - AP Online | HighBeam … - Jun 17, 2005 FDA Approves New Antibiotic Tygacil ... find AP Online articles. AP Online 06-17-2005 Dateline: WASHINGTON The government approved a new antibiotic Thurs... Pay-Per-View - AP Online - HighBeam Research FDA OKs Wyeth's novel antibiotic Tygacil.(Food and Drug Administration... - Jun 27, 2005 The US Food and Drug Administration has cleared Wyeth Pharmaceuticals' Tygacil (tigecycline), a novel, intravenous, broad-spectrum antibiotic which is also ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Press Release: New Data Highlight TYGACIL (tigecycline) In Vitro... - Dec 16, 2005 New Data Highlight TYGACIL (tigecycline) In Vitro Activity Against Resistant Gram-Negative and Extended-Spectrum Beta-Lactamase-Producing Bacteria. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Wyeth's Tygacil cleared in European Union - May 8, 2006 US drug major Wyeth says that its broad-spectrum antibiotic Tygacil (tigecycline) has become the first-in-class glycylcycline to be approved in Europe for ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones … Wyeth received FDA approval for Tygacil (tigecycline).(Pipeline) -... - Aug 1, 2005 Wyeth received FDA approval for Tygacil (tigecycline).(Pipeline) ... find Medical Marketing & Media articles. Wyeth received FDA approval for Tygacil ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Wyeth's Tygacil comparable to J&J's Levaquin - Oct 2, 2006 The USA's Wyeth Pharmaceuticals presented strong Phase III study data on its first-in-class glycylcycline antibiotic Tygacil (tigecycline) in patients with ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Wyeth launches Tygacil in the UK. - Aug 31, 2006 Wyeth launched Tygacil (tigecyclin) in Great Britain for the treatment of ... Tygacil is an intravenous glycylcyclin antibiotic which inhibits the ... Pay-Per-View - Die Pharmazeutische Industrie - Factiva, from Dow Jones Federal Register 2007 - 72 FR 7664 Determination of Regulatory Review... - Feb 16, 2007 FDA recently approved for marketing the human drug product TYGACIL (tigecycline). TYGACIL is indicated for the treatment of infections caused by susceptible ... Pay-Per-View - Federal Register 2007 - Loislaw IN BRIEF: Tygacil.(product information)(Brief article) - May 13, 2006 Tygacil from Wyeth is an antibiotic for the treatment of complicated skin, soft tissue and intra-abdominal infections. A hospital-only product, ... $4.95 - Chemist & Druggist - ECNext Cubist Pharmaceuticals Statement on the Death of Dr. Francis P. Tally. - Oct 3, 2006 Frank also played an important role in the development of three other antibiotics: Suprax, Zosyn, and what now has been introduced as Tygacil. ... Free with registration - Business Wire - AccessMyLibrary.com Growing Antibacterial Resistance Set to put Antibiotic R&D Back in... - Oct 19, 2005 The product, tigecycline (Tygacil) joins the oxazolidinones (Pfizer's linezolid) and lipopeptides (Cubist's daptomycin) in a small but growing arsenal ... Infection Control Today Event Brief of Q3 2005 WYETH Earnings Conference Call - Part 1. - Oct 2, 2005 Tygacil: 1. The Co.'s another broad spectrum IV antibiotic. 2. Soon to come are the products in WYE's late stage pipeline led by DVS-233 in depression where ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Tigecycline (Tygacil) - Sep 1, 2005 By Jessica C. Song, MA, PharmD, and Hyunah Eom, PharmD. Jessica Song is Assistant Professor of Pharmacy Practice, University of the Pacific, Stockton, CA. ... Pay-Per-View - Infectious Disease Alert - Factiva, from Dow Jones New way to fight bacteria wins | Article from The Record (Bergen... - Jun 17, 2005 Madison-based Wyeth announced the approval of Tygacil, which had been under ... Administered intravenously, Tygacil will be given in the hospital, ... Pay-Per-View - The Record - HighBeam Research Wyeth Pharmaceuticals отзывает документы на Tygacil в Европе - Apr 28, 2008 ПредÑ?тавители американÑ?кой компании Wyeth Pharmaceuticals Ñ?ообщили об отзыве из европейÑ?ких регулирующих органов документов, которые были поданы длÑ? ... ФармацевтичеÑ?кий веÑ?тник Wyeth Antibiotic Is Under Review As Last Line Against Super Bugs - May 31, 2005 The drug, Tygacil, has been successful in clinical trials, leading the US Food and Drug ... Wyeth predicts Tygacil could be approved as early as next month. ... Subscription - Wall Street Journal Online - Dow Jones & Company Wyeth launches tigecycline in India - May 25, 2007 Wyeth Ltd has introduced Tygacil (tigecycline) in selected cities of India ... Tygacil is the first antibiotic in a new class called glycylcyclines. ... pharmabiz.com æƒ æ°?è®¡åˆ’æŽ¨å‡ºæ–°åž‹æŠ—ç”Ÿç´ - Feb 16, 2005 Tygacil是æ??äº¤æ³¨å†Œå®¡æ‰¹çš„ç§°ä¸ºç”˜æ°¨é…°ç±»ï¼ˆæ–°ä¸€ç±»æŠ—ç”Ÿç´ ï¼‰çš„ç¬¬ä¸€ä¸ªå“?ç§?。 ... æƒ æ°?æ£åŠªåŠ› 寻求市场的批准，以使Tygacil能作为一ç§?对以下疾病患者的å?•ä¸€è?¯ç‰©æ²»ç–—手段：由é?© ... 人民网 æƒ æ°?制è?¯æŠ—ç”Ÿç´ Tygacil获FDA许å?¯ - Jun 17, 2005 ...ã€?MarketWatch纽约6月16日讯】周四，美国食å“?å’Œè?¯ç‰©ç®¡ç?†å±€(FDA)准许制è?¯å•†ï¼šæƒ æ°?制 è?¯(WYE)生产的一ç§?æ–°åž‹å¼ºæ•ˆæŠ—ç”Ÿç´ ä¸Šå¸‚ã€‚è¿™ç§?æ–°è?¯å?¯æ²»ç–—ç”±è€?è?¯æ€§ç»†è?Œæ‰€å¯¼è‡´çš„感染。 ... 新浪网 Empresas.- 'Tygacil' (Wyeth) actúa frente a los microorganismos diana... - Nov 7, 2008 El fármaco tigeciclina, comercializado por Wyeth como 'Tygacil', presenta una gran resistencia frente a los microorganismos diana en el paciente con sepsis ... ecodiario … : Nuevo antibiótico de amplio espectro Tygacil[x] (tigeciclina)... - May 2, 2006 ...-- Nuevo antibiótico proporciona una nueva arma para los hospitales europeos en su lucha contra las complicadas infecciones dermatológicas e ... elEconomista.es … DE AMPLIO ESPECTRO TYGACIL® RECIBE LA AUTORIZACIÓN DE … - Oct 31, 2006 La comercialización en España de Tygacil®, con su amplio espectro de actividad que incluye microorganismos multirresistentes, permite disponer de una nueva ... acceso.com TYGACIL RECIBE “OPINIÓN POSITIVAâ€? DE LAS AUTORIDADES … - Mar 16, 2006 Madrid, 16 de marzo de 2006 – Wyeth Pharmaceuticals acaba de anunciar que ha recibido una “opinión positivaâ€? por parte del Comité para Medicamentos de Uso ... acceso.com 未æ?¥ä¸¤å¹´â€œæƒ æ°?â€?将在ä¸å›½ä¸Šå¸‚三个新è?¯ - May 24, 2006 ...超过了10亿美元的疫苗，去年销售é¢?已达17亿美元；生物制剂Enbral，这也是一个“é‡? 磅炸弹â€?ï¼Œæ˜¯æƒ æ°?å…¨ç?ƒé”€é‡?最大的è?¯ï¼ŒåŽ»å¹´è¾¾åˆ°äº†37äº¿ç¾Žå…ƒï¼›æŠ—ç”Ÿç´ Tygacil，被国内称 ... æ?œç‹? Uudesta antibiootista apu MRSA-sairaalabakteeriin - May 4, 2006 Tigesykliinin kauppanimi on Tygacil ja sitä annostellaan vain suonensisäisesti. Se sopii näin parhaiten sairaalakäyttöön. Tigesykliinin etu on, että se ... Etelä-Suomen Sanomat Article: FDA Approves New Antibiotic - AP Online | HighBeam Research ... - Jun 16, 2005 Tygacil, known chemically as tigecycline, is an intravenous antibiotic, ... Tygacil is the first in a new class of antibiotics, derived from the older ... Pay-Per-View - AP Online - HighBeam Research Article: Agency approves new antibiotic to fight infections - AP … - Jun 16, 2005 Tygacil, known chemically as tigecycline, is an intravenous antibiotic, ... Tygacil is the first in a new class of antibiotics, derived from the older ... Pay-Per-View - AP Worldstream - HighBeam Research In man vs. microbe, germs will lose - Jun 23, 2005 Tygacil is the first antibiotic approved in a new class called ... The major drawback of Tygacil is that it must be administered intravenously, ... SitNews EL NUEVO ANTIBIÓTICO TYGACIL® PERMITE TRATAR CEPAS DE … - Nov 21, 2006 En la última década han aumentado significativamente los mecanismos de resistencia de Acinetobacter baumannii, un microorganismo responsable de casi el 7 ... acceso.com Aprobado en la UE el antibiótico tigecilina (Tygacil) - May 5, 2006 La Agencia Europea del Medicamento (EMEA) ha aprobado el uso del antibiótico de amplio espectro tigecilina, comercializado por Wyeth Pharmaceuticals como ... doyma.es Wyeth Reports Earnings Results for the 2005 Second Quarter and First ... - Jul 20, 2005 We expect the recent introduction of Tygacil to be followed closely by other ... Tygacil is indicated for the treatment of complicated intra-abdominal ... $4.95 - PR Newswire - ECNext Approves Antibiotic To Treat Serious Bacterial Infections - Jun 17, 2005 FDA on Thursday approved Tygacil, an antibiotic developed by Wyeth, ... Tygacil, an intravenous medication, will serve as a first-line treatment for ... Pay-Per-View - American Health Line - Factiva, from Dow Jones … : Nuevo antibiótico de amplio espectro Tygacil[x] (tigeciclina)... - May 2, 2006 Las declaraciones de este comunicado de prensa que no son hechos históricos son declaraciones prospectivas basadas en expectativas actuales sobre eventos ... elEconomista.es WYETH at SG Cowen & Co. 25th Annual Health Care Conference - … - Mar 15, 2005 Last year we submitted Tygacil, and we now have priority review status for ... We have Tygacil, Bazedoxifene, we have Temsirolimus for three different kinds ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com CDC targets stubborn germs in hospitals, New rules aimed at drug- … - Dec 27, 2005 Other products that sometimes work against MRSA include Wyeth's Tygacil and Cubist Pharmaceuticals Inc.'s Cubicin. Vancomycin is a generic drug sold by ... Pay-Per-View - Newsday - ProQuest Archiver Wyeth Boosts '06 Profit Forecast - Oct 6, 2006 It also expects big things from Tygacil, now sold to treat complicated skin and abdominal infections, if the antibiotic gains approval for a common form of ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Analysts: 'High Risk, High Reward' - Nov 26, 2007 Yet another player in the space: Tygacil (tigecycline), ... Wyeth plans to finish new Phase III trials with Tygacil for hospital-acquired pneumonia prior to ... BioWorld Online - BioWorld Online Killer Germs in Hospitals Spur Testing, Drug Markets - Sep 26, 2006 ...``That suggests that Tygacil will be an important option for patients with serious and complicated hospital infections,'' says Loh, 47. ... Bloomberg FDAç»™äºˆæ›¿åŠ çŽ¯ç´ æ–°è?¯ä¼˜å…ˆè¯„估地ä½? - Mar 27, 2008 Tygacil是æ??äº¤æ³¨å†Œå®¡æ‰¹çš„ç§°ä¸ºç”˜æ°¨é…°ç±»ï¼ˆæ–°ä¸€ç±»æŠ—ç”Ÿç´ ï¼‰çš„ç¬¬ä¸€ä¸ªå“?ç§?。 ... æƒ æ°?æ£åŠªåŠ› 寻求市场的批准，以使Tygacil能作为一ç§?对以下疾病患者的å?•ä¸€è?¯ç‰©æ²»ç–—手段：由é?© ... å?ƒé¾™ç½‘ Drug Development; Pharmaceutical company seeks global regulatory … - Jan 10, 2005 Wyeth is seeking market approval for Tygacil as a single agent therapy to ... The most common adverse events associated with Tygacil in clinical trials were ... Pay-Per-View - Gastroenterology Week - Factiva, from Dow Jones Article: CLOSER LOOK RESEARCH FINDINGS - The Milwaukee Journal … - Jan 21, 2008 Article: Wyeth Pharmaceuticals' Antibiotic TYGACIL Receives ... PR Newswire; March 2, 2006 ; 700+ words ... ... FirstCall/ -- Wyeth Pharmaceuticals ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Drug Development; Pharmaceutical company seeks global regulatory … - Jan 14, 2005 Wyeth is seeking market approval for Tygacil as a single agent therapy to ... The most common adverse events associated with Tygacil in clinical trials were ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones Wyeth Gets FDA Approval for Drug | Article from AP Online | HighBeam ... - Jun 17, 2005 The agency approved Tygacil to treat complicated intra-abdominal infections and ... Madison-based Wyeth Co. said it plans to launch Tygacil soon. ... Pay-Per-View - AP Online - HighBeam Research Upside Endeavors has been engaged for global publication management … - Nov 1, 2005 Upside Endeavors has been engaged for global publication management and US advocacy development for Wyeth's injectable antibiotic Tygacil (tigecycline). Pay-Per-View - Medical Marketing & Media - HighBeam Research Upside Endeavors has been engaged for global publication management … - Nov 1, 2005 Tygacil is now approved as a single agent therapy to treat patients with complicated intra-abdominal infections (cIAI) and complicated skin and skin ... $9.94 - Medical Marketing & Media - Alacra Store J&J, Pfizer Drugs May Reap $1 Billion Fighting Germs - Nov 8, 2007 Wyeth's Tygacil, the first in a new family of medicines for MRSA known as glycylcyclines, was introduced in 2005 and will have peak sales of more than $1 ... Bloomberg Press Release: Frost & Sullivan: Need for Complete Linked Healthcare ... - Mar 5, 2007 Article: New Broad-Spectrum Antibiotic Tygacil[x] (tigecycline) Receives ... ... Tygacil is ... either in the hospital or in the community . ... Pay-Per-View - PR Newswire Europe - HighBeam Research The recalled diet drug's maker surprised markets with a loss of $1.76... - Feb 1, 2005 If approved by the FDA, Tygacil could be launched this year. Bernard J. Poussot, head of the pharmaceutical division in Upper Providence, said Wyeth was "on ... $2.95 - Philadelphia Inquirer - NewsBank El 35% de los pacientes crÃticos presenta infecciones con resistencia... - Apr 23, 2008 La tigeciclina (Tygacil®) es activa frente a numerosas bacterias ... Tigeciclina (Tygacil®) es el primer antibiótico aprobado de una nueva clase llamada ... acceso.com Focus on rebuilding: Wyeth: pipeline to watch.(Wyeth) - Mar 1, 2005 Tygacil, comprising the main ingredient tigecycline, is being developed ... Wyeth has submitted a global registration dossier for Tygacil in December 2004. ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |